Moneycontrol PRO
Loans
Loans
HomeNewsTrendsHealthCoronavirus lockdown | Govt's fresh guidelines to help ease operations of pharma companies, medical device makers

Coronavirus lockdown | Govt's fresh guidelines to help ease operations of pharma companies, medical device makers

Manufacturing units of essential goods, including drugs, pharmaceuticals, medical devices, medical oxygen and their raw material and intermediates will be allowed to function subject to social distancing norms specified by the government.

April 15, 2020 / 12:26 IST
Representative Image (AP)

The Ministry of Home Affairs on April 15 issued fresh guidelines that may ease restrictions on the manufacture and supply of medicines and medical devices after April 20.

Manufacturing units of essential goods, including drugs, pharmaceuticals, medical devices, medical oxygen and their raw material and intermediates will be allowed to function subject to social distancing norms specified by the government.

Manufacturing units of packaging material was also allowed. E-pharmacies can now operate without any restriction on their timing of opening and closure as they come under e-commerce services.

Follow our LIVE Updates on the coronavirus pandemic here

Private vehicles for emergency services, including medical and veterinary care, and for procuring essential commodities are allowed.

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

Construction of medical, health infrastructure including the manufacture of ambulances is also allowed. This helps pharma and medical devices to resume their capital expansion work.

These relaxations will not apply to containment zones.

Healthcare services to remain open

All health services including AYUSH (Ayurveda, Unani, Siddha and Homeopathy) to remain functional. Dispensaries, chemists, pharmacies all kinds of medicine shops including Jan Aushadhi Kendras and medical equipment shops will remain open.

Pharmaceutical and medical research labs, collection centres, institutions carrying out COVID-19 related research are allowed to remain open. Veterinary hospitals, dispensaries, clinics, pathology labs, sale and supply of vaccine and medicine will be open.

Authorised private establishments, which support the provisioning of essential services, or efforts for containment of COVID-19, including home care providers, diagnostics, supply chain firms serving hospitals will also remain open.

Find other stories related to MHA guidelines on Lockdown 2.0 here.

Follow our full COVID-19 coverage here

Viswanath Pilla
Viswanath Pilla is a business journalist with 14 years of reporting experience. Based in Mumbai, Pilla covers pharma, healthcare and infrastructure sectors for Moneycontrol.
first published: Apr 15, 2020 12:26 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

  • On Saturdays

    Find the best of Al News in one place, specially curated for you every weekend.

  • Daily-Weekdays

    Stay on top of the latest tech trends and biggest startup news.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347